Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Sorrento Therapeutics expands clinical development program for resiniferatoxin

April 15, 2019

Fully human stem cells show heart muscle regeneration promise

April 9, 2019

United Therapeutics discontinues development of esuberaprost based on BEAT results in PAH

April 8, 2019

Stem cell-derived human 'hearts' identify new cardiac drugs

April 4, 2019

Repair enables regeneration for blood vessels

April 4, 2019

Proteo initiates clinical development of subcutaneous Elafin

April 1, 2019

Angion Biomedica identifies Rho-associated protein kinase 1/2 inhibitors

March 28, 2019

AnGes obtains conditional approval in Japan for HGF plasmid in critical limb ischemia

March 27, 2019

Onoact gains approval in Japan for refractory and urgent fatal arrhythmia

March 26, 2019

Vyndaqel approved in Japan for transthyretin amyloid cardiomyopathy

March 26, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...